Trimeris, Inc. (TRMS) Cash Flow Statement

Net income	-59.6M
Patent costs expensed and amortized
Amortization of deferred revenue-Roche
Stock compensation expense
Accrued marketing costs
Accounts receivable-Roche	60K
Prepaid expenses
Advanced payment-Roche
Accounts payable	-545K
Taxes payable
Accrued compensation
Accrued expenses
Net cash provided by (used in) operating activities
Maturities of investment securities available-for-sale
Patent costs
Net cash (used in) provided by investing activities
Proceeds from exercise of stock options	5.77M
Net cash provided by financing activities
Net increase in cash and cash equivalents	15.92M
Cash and cash equivalents, beginning of period	82.65M
Cash and cash equivalents, end of period	98.58M

Entities mentioned with TRMS

View All Entities